Performance of Rapid Antigen Tests for COVID-19 Diagnosis: A Systematic Review and Meta-Analysis.
Performance of Rapid Antigen Tests for COVID-19 Diagnosis: A Systematic Review and Meta-Analysis.
复制标题
DOI:
10.3390/diagnostics12010110
复制
发表时间:
2022-01-04
期刊:
影响因子:
--
通讯作者:
Aziah I
中科院分区:
文献类型:
--
作者:
Khalid MF;Selvam K;Jeffry AJN;Salmi MF;Najib MA;Norhayati MN;Aziah I
The identification of viral RNA using reverse transcription quantitative polymerase chain reaction (RT-qPCR) is the gold standard for identifying an infection caused by SARS-CoV-2. The limitations of RT-qPCR such as requirement of expensive instruments, trained staff and laboratory facilities led to development of rapid antigen tests (RATs). The performance of RATs has been widely evaluated and found to be varied in different settings. The present systematic review aims to evaluate the pooled sensitivity and specificity of the commercially available RATs. This review was registered on PROSPERO (registration number: CRD42021278105). Literature search was performed through PubMed, Embase and Cochrane COVID-19 Study Register to search studies published up to 26 August 2021. The overall pooled sensitivity and specificity of RATs and subgroup analyses were calculated. Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) was used to assess the risk of bias in each study. The overall pooled sensitivity and specificity of RATs were 70% (95% CI: 69–71) and 98% (95% CI: 98–98), respectively. In subgroup analyses, nasal swabs showed the highest sensitivity of 83% (95% CI: 80–86) followed by nasopharyngeal swabs 71% (95% CI: 70–72), throat swabs 69% (95% CI: 63–75) and saliva 68% (95% CI: 59–77). Samples from symptomatic patients showed a higher sensitivity of 82% (95% CI: 82–82) as compared to asymptomatic patients at 68% (95% CI: 65–71), while a cycle threshold (Ct) value ≤25 showed a higher sensitivity of 96% (95% CI: 95–97) as compared to higher Ct value. Although the sensitivity of RATs needs to be enhanced, it may still be a viable option in places where laboratory facilities are lacking for diagnostic purposes in the early phase of disease.
登录
查看更多内容
DOI:
10.1016/j.jinf.2021.02.014
发表时间:
2021-03
期刊:
The Journal of infection
影响因子:
--
作者:
Bulilete O;Lorente P;Leiva A;Carandell E;Oliver A;Rojo E;Pericas P;Llobera J;COVID-19 Primary Care Research Group
通讯作者:
COVID-19 Primary Care Research Group
DOI:
10.1016/j.jcv.2021.104838
发表时间:
2021-06
期刊:
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
影响因子:
--
作者:
Bianco G;Boattini M;Barbui AM;Scozzari G;Riccardini F;Coggiola M;Lupia E;Cavallo R;Costa C
通讯作者:
Costa C
DOI:
10.1016/j.jiac.2020.11.021
发表时间:
2021-04
期刊:
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
影响因子:
--
作者:
Aoki K;Nagasawa T;Ishii Y;Yagi S;Okuma S;Kashiwagi K;Maeda T;Miyazaki T;Yoshizawa S;Tateda K
通讯作者:
Tateda K
DOI:
10.1016/j.diagmicrobio.2021.115434
发表时间:
2021-10
影响因子:
2.9
作者:
Baccani I;Morecchiato F;Chilleri C;Cervini C;Gori E;Matarrese D;Bassetti A;Bonizzoli M;Mencarini J;Antonelli A;Rossolini GM
通讯作者:
Rossolini GM
DOI:
10.1016/j.ijid.2021.04.048
发表时间:
2021-07
期刊:
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
影响因子:
--
作者:
Caputo V;Bax C;Colantoni L;Peconi C;Termine A;Fabrizio C;Calvino G;Luzzi L;Panunzi GG;Fusco C;Strafella C;Cascella R;Battistini L;Caltagirone C;Salvia A;Sancesario G;Giardina E
通讯作者:
Giardina E